# The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters.

> **NCT03850314** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Prof. Tony hayek MD** · enrollment: 50 (estimated)

## Conditions studied

- Metabolic Syndrome
- Dyslipidemias
- Diabetes Mellitus
- Obesity
- Atherosclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** Glycine

## Key facts

- **NCT ID:** NCT03850314
- **Lead sponsor:** Prof. Tony hayek MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03
- **Primary completion:** 2019-12
- **Final completion:** 2020-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03850314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03850314, "The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03850314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*